As shown in Supplementary Fig. 11, the results are encouraging in that the top selected codes include the highly important laboratory tests for monitoring COVID progression (e.g., D-dimer, CRP, Ferritin) and medications for managing COVID patients (e.g., norepinephrine often used as first-line vasoactive, cefepime for managing bacteria pneumonia complications, tocilizumab, dexamethasone, and remdesivir) as well as related diagnoses and complications (e.g., viral pneumonia, respiratory insufficiency, shock, and kawasaki disease). The gene discussed is CRP; the disease is Respiratory insufficiency.